Evidence map›Paper›PMID 34864359›Full record

ReviewComputerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society2022

A community-based approach to image analysis of cells, tissues and tumors.

CSBC/PS-ON Image Analysis Working Group, Juan Carlos Vizcarra, Erik A Burlingame, Clemens B Hug, Yury Goltsev, Brian S White, Darren R Tyson, Artem Sokolov

Abstract readReview
In one paragraph

Review in Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

CSBC/PS-ON Image Analysis Working Group
Juan Carlos VizcarraDepartment of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA, USA.
Erik A BurlingameComputational Biology Program, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Clemens B HugLaboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA.
Yury GoltsevDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Brian S WhiteComputational Oncology, Sage Bionetworks, Seattle, WA, USA.
Darren R TysonDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Artem SokolovLaboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Electronic address: artem_sokolov@hms.harvard.edu.

Funding

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule DrugsU54CA225088 · NCI · HARVARD MEDICAL SCHOOL · PI SHARPE, ARLENE H. · 2018 to 2022
$10.8M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEMIR, EMEK, HEISER, LAURA MADELINE · 2017 to 2021
$10.3M
Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY · 2018 to 2023
$9.7M
Single-Cell Biology and Data Analysis Shared Resource (SCB-DA SR)U54CA217450 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO · 2018 to 2022
$8.5M
Coordination Center for Open Collaboration in Systems BiologyU24CA209923 · NCI · SAGE BIONETWORKS · PI BLETZ, JULIE ANN · 2016 to 2021
$7.4M
Research Specialist in Cancer Systems BiologyR50CA243783 · NCI · VANDERBILT UNIVERSITY · PI TYSON, DARREN R · 2019 to 2023
$781k
NCI NIH HHS R50 CA243783NCI NIH HHS U24 CA209923NCI NIH HHS U2C CA233280NCI NIH HHS U54 CA209988NCI NIH HHS U54 CA217450NCI NIH HHS U54 CA225088
6 · The paper itself

Abstract

Emerging multiplexed imaging platforms provide an unprecedented view of an increasing number of molecular markers at subcellular resolution and the dynamic evolution of tumor cellular composition. As such, they are capable of elucidating cell-to-cell interactions within the tumor microenvironment that impact clinical outcome and therapeutic response. However, the rapid development of these platforms has far outpaced the computational methods for processing and analyzing the data they generate. While being technologically disparate, all imaging assays share many computational requirements for post-collection data processing. As such, our Image Analysis Working Group (IAWG), composed of researchers in the Cancer Systems Biology Consortium (CSBC) and the Physical Sciences - Oncology Network (PS-ON), convened a workshop on "Computational Challenges Shared by Diverse Imaging Platforms" to characterize these common issues and a follow-up hackathon to implement solutions for a selected subset of them. Here, we delineate these areas that reflect major axes of research within the field, including image registration, segmentation of cells and subcellular structures, and identification of cell types from their morphology. We further describe the logistical organization of these events, believing our lessons learned can aid others in uniting the imaging community around self-identified topics of mutual interest, in designing and implementing operational procedures to address those topics and in mitigating issues inherent in image analysis (e.g., sharing exemplar images of large datasets and disseminating baseline solutions to hackathon challenges through open-source code repositories).

Indexed as

Image Processing, Computer-AssistedNeoplasmsDiagnostic ImagingHumansSoftwareTumor MicroenvironmentCell type callingImage analysisImage registrationImage segmentation

Identifiers

PMID34864359
PMCPMC8761177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.